Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Moderna, Inc. - Common Stock
(NQ:
MRNA
)
29.89
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 16, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Moderna, Inc. - Common Stock
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
99
100
Next >
CDC Advisor Panel Recommends RSV Shots In US For People Above 75 Years, Analyst Says Decision Negative For GSK
↗
June 27, 2024
The CDC's ACIP recommends RSV vaccines for adults 75+, and for those 60-74 with chronic conditions. GSK's Arexvy is approved for adults 50-59 at risk. A decision on adults 50-59 is pending further...
Via
Benzinga
2 Stocks Down More Than 30% to Buy Right Now
↗
June 27, 2024
These stocks have suffered as the demand for their biggest product -- the coronavirus vaccine -- waned.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
↗
June 26, 2024
Via
Benzinga
Dow Nearly 100 Points Lower Amid Slumping Home Sales
↗
June 26, 2024
Via
Talk Markets
Topics
Stocks
Why Is Moderna Stock Trading Lower On Wednesday?
↗
June 26, 2024
The CDC's Advisory Committee on Immunization Practices is set to discuss recommendations for RSV, influenza, and COVID-19 vaccines. Moderna's data shows vaccine efficacy drops to 50% after 18 months in...
Via
Benzinga
Moderna's Options: A Look at What the Big Money is Thinking
↗
June 24, 2024
Via
Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth $900 Today
↗
June 21, 2024
Via
Benzinga
Market Whales and Their Recent Bets on MRNA Options
↗
June 20, 2024
Via
Benzinga
Moderna Crumbles After RSV Vaccine Effectiveness Pales Vs. Pfizer, GSK Shots
↗
June 26, 2024
After 18 months, Moderna's RSV vaccine proved about 50% effective against lower respiratory tract disease.
Via
Investor's Business Daily
Beating Cancer Is Still An Everything-But-Easy Challenge That Pharmaceutical Companies Cannot Solve Overnight
↗
June 26, 2024
On Tuesday, Merck Group revealed an unexpected decision to end a Phase III trial of its cancer drug Xevinapant. This move threatens to undermine confidence the research abilities of the Darmstadt,...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
June 25, 2024
Via
Benzinga
What's Going On With Eli Lilly Stock On Tuesday?
↗
June 25, 2024
Eli Lilly collaborates with Microsoft-backed OpenAI to leverage generative AI for developing novel antimicrobials targeting drug-resistant pathogens. This partnership supports Lilly's commitment to...
Via
Benzinga
Topics
Artificial Intelligence
S&P 500, Nasdaq Lurking Below Record Highs
↗
June 18, 2024
Stocks are scattered this afternoon, as investors digest a weaker-than-expected retail sales reading from May.
Via
Talk Markets
Topics
Stocks
Smart Money Is Betting Big In MRNA Options
↗
June 11, 2024
Via
Benzinga
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
↗
June 18, 2024
AstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug Administration for its blockbuster cancer drug Imfinzi combined with chemotherapy being used as a...
Via
Benzinga
The RBA Kept Interest Rates On Hold And Remained Hawkish
↗
June 18, 2024
The Reserve Bank of Australia kept the cash rate at 4.35% at its June meeting, leaving borrowing costs unchanged for the fifth time.
Via
Talk Markets
OpenAI And Color Health Develop AI-Driven Cancer Care Solutions: Report
↗
June 17, 2024
OpenAI and startup Color Health have developed an AI assistant, named 'copilot', to support physicians in creating personalized cancer care plans, emphasizing the tool's role in augmenting rather than...
Via
Benzinga
Topics
Artificial Intelligence
Moderna Stock Soars on Cutting-Edge Personalized Cancer Vaccines
June 17, 2024
Biotechnology firm Moderna Inc. (NASDAQ: MRNA) made mainstream headlines during the pandemic for its COVID-19 vaccines. Moderna is focused on messenger RNA
Via
MarketBeat
Moderna Just Gave Investors Another Reason to Buy the Stock
↗
June 16, 2024
The company's post-pandemic prospects are getting brighter.
Via
The Motley Fool
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation COVID-19 Vaccine
June 13, 2024
Via
ACCESSWIRE
7 Struggling Stocks to Sell Before July 2024
↗
June 12, 2024
The stock market is riding high for now. But even a roaring bull market can't save these seven stocks to sell.
Via
InvestorPlace
3 Vaccine Stocks to Buy as the FDA Cracks Down on New Variants
↗
June 11, 2024
After the FDA's authorization of a Covid19 booster shot, you may want to consider adding these vaccine stocks to your portfolio.
Via
InvestorPlace
Moderna, Inc. (MRNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
June 10, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
What's Going On With Moderna Stock Monday?
↗
June 10, 2024
Moderna said its Phase 3 trial of mRNA-1083, an investigational combination vaccine against influenza and COVID-19, met its primary endpoints.
Via
Benzinga
Nike, Merck, General Motors, And More: CNBC's 'Final Trades'
↗
June 10, 2024
Liz Young of SoFi recommends Energy Select Sector SPDR Fund as her final trade on CNBC's Halftime Report. Jim Lebenthal of Cerity Partners picks General Motors, while Jason Snipe of Odyssey Capital...
Via
Benzinga
Moderna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK
↗
June 10, 2024
If approved, this would be the first combination vaccine based on mRNA technology to hit the market.
Via
Investor's Business Daily
Why Moderna Stock Is a No-Brainer Buy Right Now
↗
June 10, 2024
This messenger-RNA pioneer should be able to keep its rebound going.
Via
The Motley Fool
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
June 10, 2024
Via
ACCESSWIRE
3 Reasons to Buy Moderna Stock
↗
June 08, 2024
The biotech hasn't said its last word.
Via
The Motley Fool
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
↗
June 07, 2024
Moderna has submitted an FDA application for its 2024-2025 Spikevax formula, targeting the prevalent SARS-CoV-2 variant JN.1.
Via
Benzinga
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
